NIDA SUPPLEMENTAL INFORMATION TO THE NIH CAREER DEVELOPMENT (KAWARDS) PROGRAM ANNOUNCEMENTS



NIH GUIDE, Volume 24, Number 32, September 1, 1995



P.T. 34



Keywords:

  Biomedical Research, Multidiscipl 

  Clinical Medicine, General 



National Institute on Drug Abuse



PURPOSE



This supplement to the National Institutes of Health (NIH) career

development program announcements (K Awards) is intended to provide

additional information for potential applicants on the unique aspects

of National Institute on Drug Abuse (NIDA) career development

programs.  The NIH program announcements addressed in this supplement

are the following:



o  PA-95-049:  Mentored Research Scientist Development Award (K01)

o  PA-95-050:  Independent Scientist Award (K02)

o  PA-95-051:  Senior Scientist Award (K05)

o  PA-95-053:  Mentored Clinical Scientist Development Award (K08)

o  PA-95-054:  Mentored Clinical Scientists Development Program Award

(K12)



The guidelines and procedures outlined in the NIH program

announcements must be followed closely when an application is being

prepared for submission to the NIDA.  Particular attention should be

paid to the purpose of each award mechanism, its eligibility

requirements, and its review considerations.  For example, the K12

program mechanism will accommodate the research career pathways of

clinicians in fields related to NIDA's research mission.  Under the

K12 award, support will be provided to eligible institutions to

develop or enhance research training opportunities for clinicians

selected by the institution, who are training for careers as

independent researchers in the drug abuse and addiction area of

biomedical and behavioral research.  The K12 mechanism is designed to

foster the development of advanced clinical research skills through

didactic training and the mentored research experience.  Potential

applicants should contact appropriate NIDA staff for further

information.



Supplemental Information for NIDA Applicants



The RESEARCH OBJECTIVES section of each program announcement should

be followed carefully when preparing an application.  Note especially

that differences exist among various NIH Institutes regarding

allowable costs.  The unique aspects of NIDA allowable costs,

specifically in the categories of salary (all Ks) and research

development support (K01, K08), are listed below.



Salary



The NIDA contribution to the Principal Investigator's salary is

geared to the institutional base salary as follows:



Institutional Base Salary         NIDA Contribution



o  Up to $45,000                  100% of institutional base

o  $45,001 to $60,000             $45,000

o  $60,001 and over               75% of institutional base salary,

                                  up to $75,000



Research Development Support (K01, K08)



The NIDA allows for funds up to $50,000 per year for research related

costs outlined in each program announcement.



INQUIRIES



Inquiries are encouraged, particularly during the planning phase of

the application.  Direct inquiries to:



NIDA Institute Coordinator



Timothy P. Condon, Ph.D.

Office of Science Policy and Communications

National Institute on Drug Abuse

5600 Fishers Lane, Room 10A-55

Rockville, MD  20857

Telephone:  (301) 443-6072

FAX:  (301) 443-6277

Email:  [email protected]



.

Return to 1995 Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)